MDS Proteomics, Large Scale Biology Corporation, Picoliter, Cellomics | GenomeWeb

The US Patent and Trademark Office has granted MDS Proteomics US Patent 6,423,410, covering the composition and method for generating paramagnetic polymer particles for use in affinity separation of ligands. In this particular invention, entitled “Ultrasonically Generated Paramagnetic Polymer Particles,” the vinyl monomers are polymerized in the presence of high energy ultrasound. The particles contain vacuous cavities, a high percentage of evenly distributed magnetite, and are stable in both aqueous and organic solvents.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.